首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备 POC诊断

市场调查报告书

商品编码

1467581

2024-2032 年护理点分子诊断市场报告（按产品和服务、技术、应用、最终用户和地区划分）

Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2023 年，全球护理IMARC Group分子诊断市场规模达到 37 亿美元。

护理点 (POC) 分子诊断是指由医生进行的用于诊断和检测传染病的测试。它包括血液学、怀孕、生育、传染病、尿液分析检测试剂盒以及心臟代谢和血糖监测设备。 POC 分子诊断广泛用于识别传染源、微小残留疾病和胃肠道疾病，监测血红蛋白和粪便潜血，以及确定患者代谢药物或药物类别的能力。这些测试提供更快的结果，减少与虐待相关的併发症，并改善感染控制措施。因此，POC 分子诊断在医院、重症监护病房 (ICU)、研究机构、诊所、分散式实验室和家庭护理设施中得到广泛应用。

护理点分子诊断市场趋势：

全球传染病的日益流行正在为市场创造积极的前景。 POC 分子诊断测试是一种经济高效的解决方案，广泛用于管理传染病，如流感、结核病、人类免疫缺陷病毒 (HIV) 感染、衣原体和肝炎。此外，为了有效管理和控制 COVID-19 的传播，对 PCR 检测试剂盒的需求不断增长，这是另一个成长诱导因素。此外，采用小型化、奈米技术和微流体技术来开发低成本、用户友好且高灵敏度的分子诊断测试正在推动市场成长。此外，政府为改善医疗基础设施和增强分子诊断能力而实施的各种措施正在对市场成长产生积极影响。其他因素，包括脱氧核糖核酸 (DNA) 定序的快速进步、对先进治疗和诊断测试的认识不断提高、老年人口的增加以及云端连接 POC 诊断技术的最新发展，预计将推动市场成长。

本报告回答的关键问题

2023 年全球床边分子诊断市场规模有多大？
2024-2032年全球护理点分子诊断市场的预期成长率为何？
推动全球护理点分子诊断市场的关键因素是什么？
COVID-19 对全球护理点分子诊断市场有何影响？
基于产品和服务的全球护理点分子诊断市场的细分情况如何？
基于此技术的全球护理点分子诊断市场的细分情况如何？
基于应用的全球护理点分子诊断市场的细分情况如何？
全球护理点分子诊断市场的关键区域有哪些？
全球护理点分子诊断市场的主要参与者/公司有哪些？

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 市场细分：按国家/地区
- 市场预测

第 11 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 12 章：价值链分析

第 13 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 14 章：价格分析

第15章：竞争格局

市场结构
关键参与者
关键参与者简介
- Abbott Laboratories
- Becton Dickinson and Company
- Binx Health Inc.
- Co-Diagnostics Inc.
- F. Hoffmann-La Roche Ltd
- Gene STAT Molecular Diagnostics LLC
- Hemocue AB (Danaher Corporation)
- Meridian Bioscience Inc.
- Molbio Diagnostics Private Limited
- Quidel Corporation
- Siemens Healthcare GmbH (Siemens AG)
- Thermo Fisher Scientific Inc.
- Visby Medical Inc.

简介目录图表

Product Code: SR112024A6271

The global point of care molecular diagnostics market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032.

Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.

Point of Care Molecular Diagnostics Market Trends:

The increasing prevalence of infectious diseases across the globe is creating a positive outlook for the market. POC molecular diagnostic tests is a cost-effective solution widely used to manage infectious diseases, such as flu, tuberculosis, human immunodeficiency virus (HIV) infection, chlamydia, and hepatitis. Additionally, the rising demand for PCR test kits to effectively manage and control the spread of COVID-19 is acting as another growth-inducing factor. Furthermore, the adoption of miniaturization, nanotechnology, and microfluidics to develop low-cost, user-friendly, and highly sensitive molecular diagnostic tests is providing an impetus to the market growth. Moreover, the implementation of various government initiatives toward improving healthcare infrastructure and enhancing molecular diagnostic capabilities is positively influencing the market growth. Other factors, including rapid advancements in deoxyribonucleic acid (DNA) sequencing, rising awareness regarding advanced therapeutic and diagnostic tests, increasing geriatric population, and recent developments in cloud-connected POC diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global point of care molecular diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and service, technology, application and end user.

Breakup by Product and Service:

Assays and Kits

Instruments and Analyzers

Software and Services

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Hybridization

DNA sequencing

Microarray

Isothermal Nucleic Acid Amplification Technology (INAAT)

Others

Breakup by Application:

Infectious Diseases

Oncology

Hematology

Prenatal Testing

Endocrinology

Others

Breakup by End User:

Physicians' Offices

Hospitals and ICUs

Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Binx Health Inc., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, Gene STAT Molecular Diagnostics LLC, Hemocue AB (Danaher Corporation), Meridian Bioscience Inc., Molbio Diagnostics Private Limited, Quidel Corporation, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc. and Visby Medical Inc.

Key Questions Answered in This Report

1. What was the size of the global point of care molecular diagnostics market in 2023?
2. What is the expected growth rate of the global point of care molecular diagnostics market during 2024-2032?
3. What are the key factors driving the global point of care molecular diagnostics market?
4. What has been the impact of COVID-19 on the global point of care molecular diagnostics market?
5. What is the breakup of the global point of care molecular diagnostics market based on the product and service?
6. What is the breakup of the global point of care molecular diagnostics market based on the technology?
7. What is the breakup of the global point of care molecular diagnostics market based on application?
8. What are the key regions in the global point of care molecular diagnostics market?
9. Who are the key players/companies in the global point of care molecular diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Point of Care Molecular Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product and Service

6.1 Assays and kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Instruments and Analyzers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Technology

7.1 Polymerase Chain Reaction (PCR)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Hybridization
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 DNA sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Microarray
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Infectious Diseases
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Oncology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Hematology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Prenatal Testing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Endocrinology
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast

9 Market Breakup by End User

9.1 Physicians' Offices
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Hospitals and ICUs
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Research Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Becton Dickinson and Company
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Binx Health Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Co-Diagnostics Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
- 15.3.5 F. Hoffmann-La Roche Ltd
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
- 15.3.6 Gene STAT Molecular Diagnostics LLC
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Hemocue AB (Danaher Corporation)
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Meridian Bioscience Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Molbio Diagnostics Private Limited
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
- 15.3.10 Quidel Corporation
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Siemens Healthcare GmbH (Siemens AG)
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 Thermo Fisher Scientific Inc.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis
- 15.3.13 Visby Medical Inc.
  - 15.3.13.1 Company Overview
  - 15.3.13.2 Product Portfolio

简介目录图表

List of Figures

Figure 1: Global: Point of Care Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Point of Care Molecular Diagnostics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Point of Care Molecular Diagnostics Market: Breakup by Product and Service (in %), 2023
Figure 5: Global: Point of Care Molecular Diagnostics Market: Breakup by Technology (in %), 2023
Figure 6: Global: Point of Care Molecular Diagnostics Market: Breakup by Application (in %), 2023
Figure 7: Global: Point of Care Molecular Diagnostics Market: Breakup by End User (in %), 2023
Figure 8: Global: Point of Care Molecular Diagnostics Market: Breakup by Region (in %), 2023
Figure 9: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Point of Care Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Point of Care Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Point of Care Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Point of Care Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Point of Care Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Point of Care Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Point of Care Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Point of Care Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Point of Care Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Point of Care Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Point of Care Molecular Diagnostics (Hematology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Point of Care Molecular Diagnostics (Hematology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Point of Care Molecular Diagnostics (Endocrinology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Point of Care Molecular Diagnostics (Endocrinology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Point of Care Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Point of Care Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Point of Care Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Point of Care Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Point of Care Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Point of Care Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: North America: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: North America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: United States: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: United States: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Canada: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Canada: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Asia-Pacific: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Asia-Pacific: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: China: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: China: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Japan: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Japan: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: India: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: India: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: South Korea: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: South Korea: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Australia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Australia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Indonesia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Indonesia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Europe: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Europe: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Germany: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Germany: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: France: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: France: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: United Kingdom: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: United Kingdom: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Italy: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Italy: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Spain: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Spain: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Russia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Russia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Latin America: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Latin America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Brazil: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Brazil: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Mexico: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Mexico: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Middle East and Africa: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 94: Middle East and Africa: Point of Care Molecular Diagnostics Market: Breakup by Country (in %), 2023
Figure 95: Middle East and Africa: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 96: Global: Point of Care Molecular Diagnostics Industry: SWOT Analysis
Figure 97: Global: Point of Care Molecular Diagnostics Industry: Value Chain Analysis
Figure 98: Global: Point of Care Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Point of Care Molecular Diagnostics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Product and Service (in Million US$), 2024-2032
Table 3: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Point of Care Molecular Diagnostics Market: Competitive Structure
Table 8: Global: Point of Care Molecular Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219